Trichodermide D
| Internal ID | 3c622ed9-b482-4da9-99e2-ab302a03dcac |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2S)-2-[(2-acetamido-2-methylpropanoyl)amino]-N-[(2S,3S)-1-[[(2S)-1-[[1-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[[1-[(2S)-2-[[(2S)-1-hydroxy-3-methylbutan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]pentanediamide |
| SMILES (Canonical) | CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)N1CCCC1C(=O)NC(CO)C(C)C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C |
| SMILES (Isomeric) | CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@H](CO)C(C)C)NC(=O)[C@@H]2CCCN2C(=O)C(C)(C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)N)NC(=O)C(C)(C)NC(=O)C |
| InChI | InChI=1S/C57H100N12O13/c1-18-33(9)43(49(77)59-37(28-30(3)4)46(74)66-56(14,15)53(81)68-26-20-22-39(68)47(75)60-38(29-70)31(5)6)64-48(76)40-23-21-27-69(40)54(82)57(16,17)67-51(79)42(32(7)8)62-50(78)44(34(10)19-2)63-45(73)36(24-25-41(58)72)61-52(80)55(12,13)65-35(11)71/h30-34,36-40,42-44,70H,18-29H2,1-17H3,(H2,58,72)(H,59,77)(H,60,75)(H,61,80)(H,62,78)(H,63,73)(H,64,76)(H,65,71)(H,66,74)(H,67,79)/t33-,34-,36-,37-,38+,39-,40-,42-,43-,44-/m0/s1 |
| InChI Key | GNPWSZMDKPTDLE-YFGUJFNBSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C57H100N12O13 |
| Molecular Weight | 1161.50 g/mol |
| Exact Mass | 1160.75328129 g/mol |
| Topological Polar Surface Area (TPSA) | 366.00 Ų |
| XlogP | 2.70 |
| Atomic LogP (AlogP) | 0.29 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 31 |
| RefChem:191164 |
| (2S)-2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)-N-((1S,2S)-1-(((1S)-1-((1-((2S)-2-(((1S,2S)-1-(((1S)-1-((1-((2S)-2-(((2S)-1-hydroxy-3-methylbutan-2-yl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)-2-methylbutyl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-2-methylpropyl)-C-hydroxycarbonimidoyl)-2-methylbutyl)pentanediimidate |
| (2S)-2-((2-acetamido-2-methylpropanoyl)amino)-N-((2S,3S)-1-(((2S)-1-((1-((2S)-2-(((2S,3S)-1-(((2S)-1-((1-((2S)-2-(((2S)-1-hydroxy-3-methylbutan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)pentanediamide |
| (2S)-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)-N-[(1S,2S)-1-{[(1S)-1-({1-[(2S)-2-{[(1S,2S)-1-{[(1S)-1-({1-[(2S)-2-{[(2S)-1-hydroxy-3-methylbutan-2-yl]-C-hydroxycarbonimidoyl}pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}-2-methylbutyl]-C-hydroxycarbonimidoyl}pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl}-C-hydroxycarbonimidoyl)-2-methylpropyl]-C-hydroxycarbonimidoyl}-2-methylbutyl]pentanediimidate |
| (2S)-2-[(2-acetamido-2-methylpropanoyl)amino]-N-[(2S,3S)-1-[[(2S)-1-[[1-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[[1-[(2S)-2-[[(2S)-1-hydroxy-3-methylbutan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]pentanediamide |
| CHEBI:209199 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8062 | 80.62% |
| Caco-2 | - | 0.8602 | 86.02% |
| Blood Brain Barrier | - | 0.5750 | 57.50% |
| Human oral bioavailability | - | 0.5571 | 55.71% |
| Subcellular localzation | Lysosomes | 0.7139 | 71.39% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8711 | 87.11% |
| OATP1B3 inhibitior | + | 0.9360 | 93.60% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.9588 | 95.88% |
| P-glycoprotein inhibitior | + | 0.7432 | 74.32% |
| P-glycoprotein substrate | + | 0.8452 | 84.52% |
| CYP3A4 substrate | + | 0.7129 | 71.29% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.5863 | 58.63% |
| CYP2C9 inhibition | - | 0.8763 | 87.63% |
| CYP2C19 inhibition | - | 0.7818 | 78.18% |
| CYP2D6 inhibition | - | 0.8825 | 88.25% |
| CYP1A2 inhibition | - | 0.9018 | 90.18% |
| CYP2C8 inhibition | + | 0.5000 | 50.00% |
| CYP inhibitory promiscuity | - | 0.9779 | 97.79% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7500 | 75.00% |
| Carcinogenicity (trinary) | Non-required | 0.6140 | 61.40% |
| Eye corrosion | - | 0.9797 | 97.97% |
| Eye irritation | - | 0.8967 | 89.67% |
| Skin irritation | - | 0.7783 | 77.83% |
| Skin corrosion | - | 0.8667 | 86.67% |
| Ames mutagenesis | - | 0.7200 | 72.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3885 | 38.85% |
| Micronuclear | + | 0.6000 | 60.00% |
| Hepatotoxicity | + | 0.5532 | 55.32% |
| skin sensitisation | - | 0.8723 | 87.23% |
| Respiratory toxicity | + | 0.7111 | 71.11% |
| Reproductive toxicity | + | 0.7667 | 76.67% |
| Mitochondrial toxicity | + | 0.7250 | 72.50% |
| Nephrotoxicity | + | 0.4829 | 48.29% |
| Acute Oral Toxicity (c) | III | 0.6752 | 67.52% |
| Estrogen receptor binding | + | 0.6638 | 66.38% |
| Androgen receptor binding | + | 0.7424 | 74.24% |
| Thyroid receptor binding | + | 0.6252 | 62.52% |
| Glucocorticoid receptor binding | + | 0.7240 | 72.40% |
| Aromatase binding | + | 0.7274 | 72.74% |
| PPAR gamma | + | 0.7872 | 78.72% |
| Honey bee toxicity | - | 0.8191 | 81.91% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6200 | 62.00% |
| Fish aquatic toxicity | - | 0.5102 | 51.02% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.69% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.62% | 98.95% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 99.21% | 98.94% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.88% | 97.25% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.60% | 98.33% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.41% | 94.45% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.32% | 93.56% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.87% | 96.85% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.83% | 96.09% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.57% | 92.38% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.72% | 100.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.70% | 96.67% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.66% | 98.10% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 95.30% | 96.03% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 94.98% | 95.38% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 94.76% | 98.24% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 94.75% | 83.14% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 94.63% | 100.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.57% | 94.66% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.43% | 91.19% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.43% | 97.09% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.38% | 96.47% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.79% | 100.00% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.75% | 97.64% |
| CHEMBL3468 | P55210 | Caspase-7 | 93.50% | 95.68% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 93.48% | 97.50% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.93% | 97.14% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 92.62% | 97.43% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 92.51% | 94.00% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 92.18% | 99.77% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 92.08% | 92.12% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 91.90% | 97.29% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.89% | 96.67% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 91.68% | 96.31% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 90.63% | 98.05% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 90.07% | 97.64% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 89.60% | 92.86% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 88.64% | 90.71% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 88.53% | 83.10% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 88.52% | 87.16% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 87.94% | 98.89% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.81% | 94.33% |
| CHEMBL204 | P00734 | Thrombin | 87.59% | 96.01% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 87.50% | 95.71% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 87.19% | 82.69% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.84% | 93.00% |
| CHEMBL3691 | Q13822 | Autotaxin | 86.50% | 96.39% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 86.41% | 98.77% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 86.26% | 97.47% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.93% | 97.50% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 85.93% | 97.23% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 85.87% | 100.00% |
| CHEMBL3776 | Q14790 | Caspase-8 | 85.70% | 97.06% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 85.29% | 99.18% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 85.24% | 88.42% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 84.95% | 96.28% |
| CHEMBL4072 | P07858 | Cathepsin B | 84.67% | 93.67% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.59% | 95.89% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 84.53% | 93.33% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 84.51% | 96.95% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 84.22% | 93.04% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 83.83% | 95.17% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 83.76% | 92.80% |
| CHEMBL5028 | O14672 | ADAM10 | 83.69% | 97.50% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 83.62% | 81.29% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 83.52% | 99.17% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 83.34% | 98.33% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.18% | 96.90% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 83.02% | 96.21% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.94% | 95.50% |
| CHEMBL268 | P43235 | Cathepsin K | 82.70% | 96.85% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 82.64% | 95.36% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 82.60% | 99.17% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 82.58% | 98.75% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 82.57% | 98.57% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 82.39% | 82.05% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 82.37% | 97.21% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 82.12% | 95.00% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 81.55% | 97.86% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 80.89% | 90.24% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 80.52% | 96.00% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 80.17% | 93.03% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 80.05% | 92.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589948 |
| LOTUS | LTS0156999 |
| wikiData | Q105013107 |